TORONTO, ON — June 21, 2002 —
As the first day of summer arrives, sweating becomes more of an issue for most people. Antiperspirants and deodorants seem to be the usual solution and most people’s worries are over! However, for millions of people around the world, including approximately 300,000 Canadians, excessive sweating, or hyperhidrosis, is a problem all year long.
According to a new Canadian clinical study published this month in Dermatologic Surgery by the American Society for Dermatologic Surgery, Botox® injections have been proven to safely and effectively treat and reduce excessive or uncontrollable sweating – a chronic disorder known as hyperhidrosis.
This condition can affect various parts of the body, including the underarms, hands, feet, and even the face. Approved in Canada in 2001 for the treatment of excessive underarm sweating (axillary hyperhidrosis), Botox therapy is administered via tiny injections within the skin of the affected area to block the release of the chemical that signals the perspiration. The study indicated that excessive sweating currently affects about one per cent of the world’s population. Conducted by Dr. Nowell Solish and Dr. Stephen R. Tan of the Department of Dermatology, University of Toronto, the study also found that Botox can dramatically improve the quality of life for patients suffering from the excessive sweating.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!